In this issue:
- GLP-1 agonist discontinuation: major adverse CV event risk in type 2 diabetes
- Heterogeneity of treatment effects of GLP-1 agonists for weight loss
- Orforglipron + insulin glargine in type 2 diabetes
- Social determinants of health and recommended HbA1c monitoring in post partum diabetes
- Screening for early-stage type 1 diabetes
- CGM vs. SMBG in type 2 diabetes
- CGM and support in primary care for Tongans with type 2 diabetes
- Adiposity-based obesity classification: cardiometabolic and kidney outcomes
- Mother and child health after GDM: tight vs. less tight glycaemic control
- HbA1c after younger age of transfer from paediatric to adult type 1 diabetes services
Please login below to download this issue (PDF)